Brainstorm Cell Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Biogen USD 7.29B 1.7M Sep/2026
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Cipla INR 4.69B 874.1M Sep/2026
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Cytokinetics USD 244.33M 3.87M Sep/2026
Gilead Sciences USD 23.82B 17M Sep/2026
Grifols EUR 9.95B 722.93M Dec/2025
Halozyme Therapeutics USD 2.94B 1.01B Sep/2026
Mesoblast USD 113.71M 47.68M Jun/2026